Showing 1 - 10 of 20
Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...
Persistent link: https://www.econbiz.de/10012464639
the israeli economy in the nineties and beyond. In this paper we present a close-up portrait of innovation in Israel for …
Persistent link: https://www.econbiz.de/10012471778
applied to the case of Computed Tomography (CT) Scanners, a revolutionary innovation in medical technology. The econometric … from innovation is used primarily to compute a social rate of return to R&D, to explore the interrelation between … innovation and diffusion, and to trace the time profile of benefits and costs, the latter suggesting the possible occurance of …
Persistent link: https://www.econbiz.de/10012477355
I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …
Persistent link: https://www.econbiz.de/10012462770
The development prospects of a poor country depend in part on its capacity for innovation. The productivity of its …
Persistent link: https://www.econbiz.de/10012464057
We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …
Persistent link: https://www.econbiz.de/10012464638
the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …
Persistent link: https://www.econbiz.de/10012466126
higher rates of lab and outpatient innovation had greater declines in the probability of missing work during 1996-2003. This … for initial disability, the inverse relationship between lab innovation and disability changes disappears. This is because … there is a significant inverse relationship between initial health and the extent of laboratory innovation. But due to …
Persistent link: https://www.econbiz.de/10012466549
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...
Persistent link: https://www.econbiz.de/10012468944
from pharmaceutical innovation. Extending previous studies of the welfare benefits from innovation (Trajtenberg, 1990 …
Persistent link: https://www.econbiz.de/10012471921